In his article, The New Metrics of Market Success, Mason Tenaglia is calling for the application of new market metrics in order for pharmaceutical companies to “align their strategies around the push for greater profitability, putting them on the right track for growth – right to the end of the product cycle.” Read More→
In his article, Product Positioning 2.0, author Dr. Stan Bernard offers the reader four i-Bite (information bites) ways to position products.
- Sooner – Be first sooner
- Simpler – Be “i-Bite” concise
- Better – Create a better product perception
- Clearer – Clarify and consistently communicate your positioning
This advice is based on the understanding that we are now in a “Pharma 2.0” Read More→
Advanced Strategic Marketing Article Review: What Killed Michael Porter’s Monitor Group? The One Force That Really Matters (Forbes)
Whatever happened to Prof. Michael E. Porter and Monitor Consulting? Until 2008, Monitor (a consulting firm he helped to found with 5 partners in 1983) had grown to international prominence. However, Monitor slid financially downward after the economic recession of 2008/2009, compounded by Prof. Porter’s having been personally involved in a major scandal involving working for Gadhafi, Read More→
The ways your customers make decisions about your medicines, diagnostics and devices are changing. Are you changing too? We all know how important the internet and social media are for modern marketing, but not all marketers in the healthcare industry really understand this new area or how consumers use it in their healthcare decision-making. Read More→
Advanced Strategic Marketing Article Review: INSIDE 23ANDME FOUNDER ANNE WOJCICKI’S $99 DNA REVOLUTION
If you are a medical marketer and deal with strategic decisions, then it is critical for you to keep an eye on emerging and future technologies as well as changes in customer needs and expectations. This not only includes changes in web and electronic technologies, but also more complex scientific breakthroughs such as those in genetics, Read More→
In The Coming Revolution, author Dr. Eric Topol calls for a digital revolution by patients and consumers to overtake the stagnant world of medicine and medical practices that are unable or unwilling to move forward into the future of personalized medicine and technology enhanced healthcare. Read More→
In his Harvard Business Review article, “What makes Strategic Decisions Different“, author Phil Rosenzweig gives us a method to understand and frame decision making, and the ways in which different decisions should be made. Although his methods are useful, they are limited in the critical area of strategic decisions, Read More→
There are many win-win business opportunities for the pharmaceutical industry and people in emerging and new markets around the world. One win-win opportunity is the development of key relationships with thought leaders who are in positions of power and influence in medicine, advocacy, policy and so on. This entails getting to know the key thought leaders in these markets and establishing the trust that the company is making a true commitment. Read More→
Achieving Health and Business Outcomes: The Synergy of Combining Strategic Insight Research™ (SIR™) with Epidemiology Research and ScoreCard Modelling™
How can a company ensure that the medical products and services it offers will be able to cascade effectively to improve the health of patients and health outcomes?
To succeed, go back to the beginning. Companies not only require dependable and current epidemiology (how real is the need, Read More→
Running a strategic insights market research project internationally can be quite a daunting task. There are a number of challenges that you will face that are different from a domestic project. These include legal, language, time, physical location, and cultural barriers.
First of all, Read More→